HCPCS H0015: Intensive Outpatient Alcohol and/or Drug Treatment
Commercial payers pay $470 on average nationally for this procedure.
HCPCS Level II code H0015 describes intensive outpatient alcohol and/or drug treatment services provided as a structured program that operates at least three hours per day and at least three days per week, delivered according to an individualized treatment plan and including assessment, counseling, crisis intervention, and activity therapies or education; service type: intensive outpatient substance use disorder treatment; typical site of service: outpatient behavioral health or addiction treatment facility.
For related coverage guidance, see recent payer policy updates: Home Health, Skilled, and Custodial Care Services (for Idaho Only), Private Duty Nursing Services, Private Duty Nursing Services (for Florida Only).
Customize your policy alerts
Sign up for hcpcs H0015 policy alerts
Get alerted when payer policies referencing H0015 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial rates for HCPCS code H0015 center around BUCA's average commercial rate of $470.30, with individual payers showing materially different central tendencies and spreads. Blue Cross Blue Shield (BCBS) and Aetna exhibit higher medians near the BUCA average range, while Cigna and UnitedHealth Group display lower medians; Cigna’s median is $81.80 and UnitedHealth Group’s median is $125.00. BCBS has an extreme max outlier at $66,111.10 but its central 50% sits near typical commercial levels.
Rate dispersion measured by the interquartile range (P75 minus P25) highlights variability: BCBS has the widest IQR at $60.40 (P75 $192.60 minus P25 $132.00), indicating broader mid-range spread, followed by BUCA with an IQR of $52.50 (P75 $170.30 minus P25 $117.80). UnitedHealth Group shows a moderate IQR of $104.50 (P75 $159.50 minus P25 $52.00) driven by a low P25, while Aetna and Cigna have the tightest interquartile spreads at $4.30 and $1.10 respectively, signaling relatively concentrated mid-range pricing.